48,597
edits
Difference between revisions of "Carcinoma ex pleomorphic adenoma"
Jump to navigation
Jump to search
Carcinoma ex pleomorphic adenoma (view source)
Revision as of 14:47, 24 November 2013
, 14:47, 24 November 2013→IHC
(→IHC) |
|||
| Line 85: | Line 85: | ||
==IHC== | ==IHC== | ||
Features - ca ex PA versus PA:<ref name=pmid23821206>{{Cite journal | last1 = Di Palma | first1 = S. | title = Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions. | journal = Head Neck Pathol | volume = 7 Suppl 1 | issue = | pages = S68-76 | month = Jul | year = 2013 | doi = 10.1007/s12105-013-0454-z | PMID = 23821206 }}</ref> | Features - ca ex PA versus PA:<ref name=pmid23821206>{{Cite journal | last1 = Di Palma | first1 = S. | title = Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions. | journal = Head Neck Pathol | volume = 7 Suppl 1 | issue = | pages = S68-76 | month = Jul | year = 2013 | doi = 10.1007/s12105-013-0454-z | PMID = 23821206 }}</ref> | ||
*Ki-67 | *Ki-67 >35% of cells. | ||
*HER2 +ve | *HER2 +ve membrane staining (3+ for high-grade, 2+ or less for low-grade). | ||
*p53 +ve. | *p53 +ve. | ||
*AR +ve. | |||
Others:<ref name=pmid23821206/> | |||
*CK7 +ve. | |||
*AE1/AE3 +ve. | |||
==See also== | ==See also== | ||